Douglas Petno Buys Shares of JPMorgan Chase & Co.

Douglas Petno, Co-President at JPMorgan Chase, acquired 90,321 shares.

Key Points

  • Douglas Petno, Co-President at JPMorgan Chase, acquired 90,321 shares on June 24, 2026.
  • Shares of JPMorgan Chase traded at approximately $329.05 with a market cap of $881.7 billion.
  • Analysts maintain a positive outlook, with price targets ranging from $310 to $355.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Douglas Petno, Co-President and CEO of the Corporate & Investment Bank at JPMorgan Chase & Co., has acquired 90,321 shares of the company. This transaction, dated June 24, 2026, was not part of a pre-planned trading program.

Insider Buying and Selling at JPMorgan Chase & Co.

Several key insiders at JPMorgan Chase & Co. made significant stock transactions recently. Alongside Douglas Petno's purchase, Troy Rohrbaugh, Co-President and CEO of Consumer & Community Banking, also acquired 90,321 shares on June 24, 2026. Additionally, Jennifer Piepszak, Chief Operating Officer, and Mary Erdoes, CEO of Asset & Wealth Management, each bought 60,214 shares on the same day. On the selling side, Stacey Friedman, General Counsel, sold 5,467 and 5,468 shares on June 22 and May 20, 2026, respectively, under a Rule 10b5-1 plan.

JPMorgan Chase & Co. Stock Down 8.0%

Shares of NYSE:JPM traded near $329.05 on Saturday. JPMorgan Chase & Co. boasts a market cap of approximately $881.7 billion and a P/E ratio of 15.75. The stock has a 52-week low of $279.10 and a high of $343.45. Its 50-day moving average is $311.11, while the 200-day moving average stands at $307.97. The company's beta is 1.0, indicating it moves in line with the market.

Year to date

$JPM stock price

Daily closing prices, year to date. Not investment advice.

Analysts Set New Price Targets

Analysts have been active with their assessments of JPMorgan Chase & Co. On June 26, 2026, Truist Securities maintained a hold rating with a price target of $344. Evercore ISI Group consistently held a buy rating, with targets set at $340 on April 17 and $320 on April 6. Piper Sandler reiterated a buy rating with a $325 target on March 30, while Jefferies initiated coverage with a hold rating and a $310 target on March 26. The consensus among 21 analysts is a buy rating, with a mean price target of $342.90.

About JPMorgan Chase & Co.

JPMorgan Chase & Co. is a leading global financial services company headquartered in New York, NY. It operates through three main segments: Consumer & Community Banking, Commercial & Investment Banking, and Asset & Wealth Management. Under the leadership of CEO James Dimon, the company provides a wide array of services, including investment banking, market-making, and asset management, serving clients worldwide across various sectors.

Bottom Line

Douglas Petno's recent share purchase highlights ongoing insider activity at JPMorgan Chase, a financial giant with a significant market presence. Shares traded near $329.05, reflecting the company's robust market position. Analysts remain generally positive, with varied price targets suggesting confidence in the company's future performance.

Get JPMorgan Chase & Co. alerts

New 13F filings, insider trades, and analyst moves on $JPM, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.